Picture of DNA Chip Research logo

2397 DNA Chip Research Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapHigh Flyer

Annual income statement for DNA Chip Research, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoTanshin
Standards:
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3254283284901,091
Cost of Revenue
Gross Profit66.289.2-35.666.4570
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses4935896867491,148
Operating Profit-169-161-358-259-56.7
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-172-133-361-246-55.4
Provision for Income Taxes
Net Income After Taxes-172-134-362-248-58.2
Net Income Before Extraordinary Items
Net Income-172-134-362-248-58.2
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-172-134-362-248-58.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-30.8-23.8-62.3-390.573
Dividends per Share